-
Nintedanib (BIBF 1120): Applied Research Workflows
2026-09-10
Build reproducible Nintedanib workflows for receptor-kinase signaling, angiogenesis, apoptosis, and ATRX-stratified glioma research. This guide connects practical assay design with combination studies, fibrosis models, and troubleshooting strategies for translating multi-target inhibition into interpretable data.
-
Clozapine N-oxide for Freely Moving Brain Imaging
2026-09-09
Clozapine N-oxide (CNO) connects chemogenetic circuit control with high-throughput calcium imaging in freely moving animals. This workflow combines DREADDs-based neuronal activity modulation with volumetric microscopy, while emphasizing solubility control, matched controls, and movement-aware data analysis.
-
MRSA Extracellular Vesicles and IL-8 in Oral Cancer
2026-09-09
A 2026 study identifies methicillin-resistant Staphylococcus aureus extracellular vesicles as active drivers of oral squamous cell carcinoma proliferation rather than passive infection by-products. Its experiments connect vesicle uptake to ERK/c-Jun activation, IL-8 production, CXCR1 signaling, CCL2 secretion, and JAK/STAT5A activation, while also showing how genetic or receptor-level interruption weakens tumor growth.
-
Haloprogin BA1790: Reliable Antimicrobial Assays
2026-09-08
Learn how Haloprogin (SKU BA1790) can help laboratories design more interpretable antimicrobial, viability, and cytotoxicity workflows. This scenario-based guide covers solvent compatibility, MIC/MFC interpretation, protocol parameters, assay controls, and evidence-based product selection.
-
A-1331852 BCL-XL Inhibitor Workflow
2026-09-08
A practical guide to using A-1331852 as a selective BCL-XL inhibitor in apoptosis assays, mechanistic studies, and preclinical cancer research. The workflow emphasizes solvent handling, BAX/BAK-dependent validation, BCL-XL–BIM complex disruption, and rational combination experiments.
-
Fluo-4 AM for Calcium Imaging and Bioelectronic Assays
2026-09-07
Fluo-4 AM combines rapid cell loading with bright 488 nm fluorescence for real-time calcium signaling assays, pharmacological testing, and functional evaluation of emerging retinal interfaces. This workflow-focused guide shows how to connect intracellular calcium measurements with the ferroelectric-liquid metal photoreceptor platform while keeping optical, biological, and storage variables under control.
-
N4-Acetylcytidine: Designing Better RNA Assays
2026-09-05
N4-Acetylcytidine is more than an RNA-modification reagent: it is a defined substrate for separating nucleoside metabolism from RNA-incorporated ac4C biology. This guide translates recent ASCH-domain structural findings into stronger controls for enzyme assays, RNA epigenetics research, and structure-function studies.
-
Vitamin C in Organoid Assay Design
2026-09-05
Vitamin C and ascorbic acid are examined as controlled perturbations in cancer and hepatitis E virus organoid assays. This article translates pan-tissue HEV organoid findings into practical experimental design, dose interpretation, and stability controls.
-
4-MUG Workflows for β-Glucocerebrosidase Assays
2026-09-04
Use 4-MUG as a scalable fluorogenic readout for β-glucosidase and β-glucocerebrosidase function, from purified-enzyme kinetics to Gaucher disease cell models. The workflow below emphasizes pH-aware fluorescence, quantitative controls, mRNA-LNP assay design, and troubleshooting that separates enzyme activity from optical or matrix artifacts.
-
Pemetrexed Workflows for DNA-Repair Studies
2026-09-04
Build reproducible folate-stress assays with pemetrexed disodium across mesothelioma and lung tumor models. This workflow connects antiproliferative response, nucleotide depletion, apoptosis, senescence, and homologous-recombination phenotypes for more informative cancer chemotherapy research.
-
Hyaluronic Acid Sodium Salt for siRNA Workflows
2026-09-03
Hyaluronic acid sodium salt connects extracellular matrix modeling with practical siRNA nanoparticle, immune-cell, and organoid workflows. This guide translates the TDRD9 lung-injury study into formulation choices, assay controls, and troubleshooting steps for Sodium hyaluronate research use.
-
Belinostat (PXD101): From HDAC Biology to Translation
2026-09-03
A mechanistic and strategic guide to using Belinostat (PXD101) in epigenetic cancer research, connecting chromatin regulation, cell-cycle phenotypes, spliceosome biology, and translational assay design.
-
Making NETosis Visible in Translational Psoriasis
2026-09-02
A mechanistic and strategic guide to using HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody for high-confidence visualization of NETosis and IL-36R-linked inflammatory signaling in psoriasis research.
-
METTL16–SENP3–LTF Axis Drives HCC Ferroptosis Resistance
2026-09-02
Wang et al. identify a METTL16–IGF2BP2–SENP3–LTF regulatory axis that links m6A-dependent RNA stability, SUMO-related protein turnover, and iron handling in hepatocellular carcinoma. The findings position this pathway as a mechanistic determinant of ferroptosis resistance and a potential framework for designing ferroptosis-sensitizing studies.
-
Faropenem sodium in Viability Assays
2026-09-01
This scenario-driven guide explains how Faropenem sodium (SKU C8712) can improve interpretation of antimicrobial exposure, bacterial viability, and host-cell assay data. It connects formulation, storage, susceptibility, and transporter evidence to practical laboratory decisions without treating an antimicrobial response as direct cytotoxicity.